What is a caution with the phentermine/topiramate combination regarding monitoring?

What is a caution with the phentermine/topiramate combination regarding monitoring?

• A. Requires hospitalization
• B. Needs response review and dose adjustment
• C. No monitoring required
• D. Contraindicated in obesity

Answer: (B)

Monitoring this combination relies on regularly reviewing how well it works and how well it’s tolerated, then adjusting the dose as needed. You track weight loss progress and any adverse effects, and you tweak the dose to maximize benefit while minimizing side effects. This approach emphasizes ongoing assessment and titration rather than assuming no monitoring or requiring hospitalization. Keep in mind there are cautions that inform monitoring, such as potential cardiovascular effects (like changes in blood pressure or heart rate), cognitive or mood changes, and pregnancy risk that requires contraception and, when appropriate, pregnancy testing.

Monitoring this combination relies on regularly reviewing how well it works and how well it’s tolerated, then adjusting the dose as needed. You track weight loss progress and any adverse effects, and you tweak the dose to maximize benefit while minimizing side effects. This approach emphasizes ongoing assessment and titration rather than assuming no monitoring or requiring hospitalization. Keep in mind there are cautions that inform monitoring, such as potential cardiovascular effects (like changes in blood pressure or heart rate), cognitive or mood changes, and pregnancy risk that requires contraception and, when appropriate, pregnancy testing.